China SXT Pharmaceuticals Inc (SXTC)
0.43
-0.03
(-6.54%)
USD |
NASDAQ |
Nov 14, 16:00
0.43
0.00 (0.00%)
After-Hours: 20:00
China SXT Pharmaceuticals Total Liabilities (Quarterly): 9.197M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 9.197M |
| September 30, 2023 | 9.512M |
| September 30, 2023 | 9.512M |
| March 31, 2023 | 14.86M |
| September 30, 2022 | 7.292M |
| September 30, 2022 | 7.292M |
| March 31, 2022 | 17.12M |
| September 30, 2021 | 8.879M |
| September 30, 2021 | 8.879M |
| March 31, 2021 | 18.59M |
| Date | Value |
|---|---|
| September 30, 2020 | 5.522M |
| September 30, 2020 | 5.522M |
| March 31, 2020 | 12.30M |
| September 30, 2019 | 11.64M |
| September 30, 2019 | 11.64M |
| March 31, 2019 | 6.363M |
| September 30, 2018 | 3.992M |
| September 30, 2018 | 3.992M |
| March 31, 2018 | 4.372M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.522M
Minimum
Sep 2020
18.59M
Maximum
Mar 2021
10.34M
Average
9.197M
Median
Mar 2024
Total Liabilities (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 1.390B |
| CASI Pharmaceuticals Inc | 42.25M |
| Zai Lab Ltd | 283.19M |
| Adagene Inc | 44.19M |
| LakeShore Biopharma Co Ltd | 144.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.13M |
| Shareholders Equity (Quarterly) | 13.93M |
| Debt to Equity Ratio | 0.1731 |
| Current Ratio | 1.599 |
| Net Debt Paydown Yield | -10.78% |